Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Common name

    Oseltamivir Phosphate

    Product name Tamiflu®
    Common name

    Oseltamivir Phosphate

    Product manufacturer

    Shanghai Roche Pharmaceutical Co., Ltd.

    Product approval

    H20140344; H20140828;

    Repackaging Approval Number:J20140121

    Indication

    1.Tamiflu is indicated for the treatment of influenza in patients of 1 year of age and older (Oseltamivir Phosphate can treat type A and type B influenza effectively. However, there is not many clinical application data of Tamiflu for type A influenza.) Tamiflu shall be administrated within 48 hours of onset of symptoms of influenza.

    2.Tamiflu is indicated for the prophylaxis of type A and type B influenza in patients of 13 years of age and older.


    Specification

    75mg (based on Oseltamivir) 

    Dosage


    TAMIFLU may be taken with or without food. However, when taken with food, tolerability may be enhanced in some patients.


    Treatment of Influenza 

    Adults and Adolescents: The recommended oral dose of TAMIFLU for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily for 5 days.

    Pediatric Patients.

    The recommended oral dose of TAMIFLU oral suspension for pediatric patients 1 year and older or adult patients who cannot swallow a capsule is:

    Tamiflu®


    Prophylaxis of Influenza

    The recommended oral dose of TAMIFLU for prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual is 75 mg once daily for at least 10 days. Therapy should begin within 2 days of exposure. The recommended dose for prophylaxis during a community outbreak of influenza is 75 mg once daily. Safety and efficacy have been demonstrated for up to 6 weeks. The duration of protection lasts for as long as dosing is continued.


    3rd Floor, Weijian Health Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.